Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Prevalence of dual sensory impairment in Australia: a nationally representative population-based survey of Indigenous and non-Indigenous Australians.

The Lancet regional health. Western Pacific·2026
Same author

Health Economic Considerations for the Implementation of Artificial Intelligence-Enabled Diabetic Retinopathy Screening: A Review.

Clinical & experimental ophthalmology·2025
Same author

Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.

Journal of diabetes and metabolic disorders·2025
Same author

Prevalence of refractive error in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.

BMJ open ophthalmology·2025
Same author

Inherited retinal disease in global Indigenous populations: A scoping review.

Survey of ophthalmology·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Trachoma.

Heathcote R Wright1, Angus Turner, Hugh R Taylor

  • 1Centre for Eye Research Australia, University of Melbourne, WHO Collaborating Centre for the Prevention of Blindness, East Melbourne, VIC, Australia. heathcote27@hotmail.com

Lancet (London, England)
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

The Global Elimination of Trachoma by 2020 initiative aims to eradicate trachoma, a leading cause of preventable blindness. The SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) is proving effective in controlling this infectious eye disease.

More Related Videos

Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Background:

  • Trachoma, a keratoconjunctivitis caused by Chlamydia trachomatis, leads to scarring and blindness.
  • Active trachoma affects 84 million people, with 1.3 million blind from end-stage disease.
  • Repeated ocular infections cause conjunctival scarring, eyelid distortion, and corneal abrasion.

Purpose of the Study:

  • To evaluate the effectiveness of the Global Elimination of Trachoma by 2020 initiative.
  • To assess the impact of the SAFE strategy on trachoma control and elimination.
  • To project the potential extinction of blinding trachoma by 2020.

Main Methods:

  • Community-level interventions based on the SAFE strategy: Surgery for trichiasis, Antibiotics for active trachoma, Facial cleanliness, and Environmental improvement.
  • Review of evidence supporting the population-health initiatives.
  • Monitoring global efforts towards trachoma elimination.

Main Results:

  • The SAFE strategy demonstrates effectiveness in controlling trachoma.
  • Continued global efforts are crucial for achieving the 2020 elimination goal.
  • Evidence supports the approach for preventing further cases and blindness.

Conclusions:

  • Trachoma is on the brink of extinction due to the Global Elimination of Trachoma by 2020 initiative.
  • The SAFE strategy is a successful public health program for controlling infectious eye diseases.
  • Sustained implementation of the SAFE strategy is expected to eliminate blinding trachoma by 2020.